These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1664466)

  • 1. Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.
    ElSohly MA; Stanford DF; Harland EC; Hikal AH; Walker LA; Little TL; Rider JN; Jones AB
    J Pharm Sci; 1991 Oct; 80(10):942-5. PubMed ID: 1664466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal bioavailability of delta-9-tetrahydrocannabinol from various esters.
    Elsohly MA; Little TL; Hikal A; Harland E; Stanford DF; Walker L
    Pharmacol Biochem Behav; 1991 Nov; 40(3):497-502. PubMed ID: 1666913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition and bioavailability of various formulations of tetrahydrocannabinol in the rhesus monkey.
    Perlin E; Smith CG; Nichols AI; Almirez R; Flora KP; Cradock JC; Peck CC
    J Pharm Sci; 1985 Feb; 74(2):171-4. PubMed ID: 2985774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bypassing the first-pass effect for the therapeutic use of cannabinoids.
    Mattes RD; Shaw LM; Edling-Owens J; Engelman K; Elsohly MA
    Pharmacol Biochem Behav; 1993 Mar; 44(3):745-7. PubMed ID: 8383856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Tolerability of Δ9-THC-Hemisuccinate in a Suppository Formulation as an Alternative to Capsules for the Systemic Delivery of Δ9-THC.
    ElSohly MA; Gul W; Walker LA
    Med Cannabis Cannabinoids; 2018 Jun; 1(1):44-53. PubMed ID: 34676321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
    Adelli GR; Bhagav P; Taskar P; Hingorani T; Pettaway S; Gul W; ElSohly MA; Repka MA; Majumdar S
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2167-2179. PubMed ID: 28399267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
    Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.
    Upadhye SB; Kulkarni SJ; Majumdar S; Avery MA; Gul W; ElSohly MA; Repka MA
    AAPS PharmSciTech; 2010 Jun; 11(2):509-17. PubMed ID: 20333489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.
    Huestis MA; Cone EJ
    J Anal Toxicol; 2004 Sep; 28(6):394-9. PubMed ID: 15516285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal Physiologically Based Pharmacokinetic Model of Intravenously and Orally Administered Delta-9-Tetrahydrocannabinol in Healthy Volunteers.
    Wolowich WR; Greif R; Kleine-Brueggeney M; Bernhard W; Theiler L
    Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):691-711. PubMed ID: 31114948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.
    Hingorani T; Gul W; Elsohly M; Repka MA; Majumdar S
    J Pharm Sci; 2012 Feb; 101(2):616-26. PubMed ID: 21989812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of tetrahydrocannabinol in frequent and infrequent marijuana users.
    Kelly P; Jones RT
    J Anal Toxicol; 1992; 16(4):228-35. PubMed ID: 1323733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
    Cherniakov I; Izgelov D; Domb AJ; Hoffman A
    Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of Two Nanoemulsion Formulations of Δ
    Tagen M; Klumpers LE; Peshkovsky A
    AAPS PharmSciTech; 2023 Nov; 24(8):239. PubMed ID: 37989959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexadeutero-11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid: a superior internal standard for the GC/MS analysis of delta 9-THC acid metabolite in biological specimens.
    elSohly MA; Little TL; Stanford DF
    J Anal Toxicol; 1992; 16(3):188-91. PubMed ID: 1326061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.
    Nadulski T; Sporkert F; Schnelle M; Stadelmann AM; Roser P; Schefter T; Pragst F
    J Anal Toxicol; 2005; 29(8):782-9. PubMed ID: 16356335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH.
    Munjal M; ElSohly MA; Repka MA
    AAPS PharmSciTech; 2006 Sep; 7(3):71. PubMed ID: 17025251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vapourized Δ(9)-tetrahydrocannabinol (Δ(9)-THC) delivery system part I: development and validation of a pulmonary cannabinoid route of exposure for experimental pharmacology studies in rodents.
    Manwell LA; Charchoglyan A; Brewer D; Matthews BA; Heipel H; Mallet PE
    J Pharmacol Toxicol Methods; 2014; 70(1):120-7. PubMed ID: 24973534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal absorption of Delta(9)-tetrahydrocannabinol and WIN55,212-2 mesylate in rats.
    Valiveti S; Agu RU; Hammell DC; Paudel KS; Earles DC; Wermeling DP; Stinchcomb AL
    Eur J Pharm Biopharm; 2007 Feb; 65(2):247-52. PubMed ID: 17014999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.